Skip to main content
Clinical Trials/CTRI/2024/04/065731
CTRI/2024/04/065731
Not yet recruiting
Phase 2

A comparative study of Intrathecal hyperbaric 0.5 percent Levobupivacaine and hyperbaric 0.75 percent Ropivacaine for LSCS in preeclampsia Patients - NI

IMS, BH0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
IMS, BH
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
IMS, BH

Eligibility Criteria

Inclusion Criteria

  • Pregnant women with pre\-eclampsia undergoing LSCS

Exclusion Criteria

  • placenta previa
  • contraindication of neuraxial block
  • placental abruption
  • pulmonary edema and cyanosis
  • hepatic and renal involvement
  • BMI more than 35 kg per meter square
  • height less than 150 cm or more than 180 cm
  • HELLP syndrome
  • Multifetal pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials